Ann Acad Med Singap
-
Ann Acad Med Singap · Jan 2023
Clinical efficacy and long-term immunogenicity of an early triple dose regimen of SARS-CoV-2 mRNA vaccination in cancer patients.
Three doses of SARS-CoV-2 mRNA vaccines have been recommended for cancer patients to reduce the risk of severe disease. Anti-neoplastic treatment, such as chemotherapy, may affect long-term vaccine immunogenicity. ⋯ This study demonstrates the benefit of early administration of the third dose among cancer patients.